GLUCAGON

GLUCAGON was reported 4232 times

GLUCAGON is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MULTIPLE LENTIGINES SYNDROME 15 0.3947
1 PULMONARY VASCULITIS 175 0.3253
2 TOTAL LUNG CAPACITY ABNORMAL 111 0.2853
3 CAPILLARITIS 58 0.2101
4 SPIROMETRY ABNORMAL 109 0.1823
5 MITE ALLERGY 111 0.1695
6 NECROLYTIC MIGRATORY ERYTHEMA 6 0.1538
7 ELECTROCARDIOGRAM U WAVE PRESENT 9 0.1452
8 MYCOTIC ALLERGY 111 0.1298
9 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 94 0.1282
10 NEURITIS 176 0.1139
11 DUST ALLERGY 111 0.1131
12 ADRENAL INSUFFICIENCY NEONATAL 3 0.0882
13 CONJUNCTIVITIS ALLERGIC 114 0.0769
14 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 147 0.0720
15 SOFT TISSUE MASS 32 0.0693
16 RESPIRATORY SYMPTOM 174 0.0611
17 HYPERDYNAMIC LEFT VENTRICLE 11 0.0447
18 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 5 0.0446
19 FORCED EXPIRATORY VOLUME DECREASED 115 0.0406
20 NECROTISING SOFT TISSUE INFECTION 9 0.0390
21 NORMOCHROMIC NORMOCYTIC ANAEMIA 117 0.0389
22 OESOPHAGEAL PERFORATION 31 0.0372
23 ELECTROCARDIOGRAM P WAVE ABNORMAL 9 0.0367
24 CYTOTOXIC OEDEMA 9 0.0340
25 CSF PRESSURE INCREASED 9 0.0338
26 PULMONARY ALVEOLAR HAEMORRHAGE 177 0.0315
27 DIABETIC RETINAL OEDEMA 16 0.0315
28 NEUROLOGICAL SYMPTOM 176 0.0308
29 VASOPLEGIA SYNDROME 49 0.0299
30 CATARACT SUBCAPSULAR 17 0.0279
31 HYPOGLYCAEMIC SEIZURE 24 0.0264
32 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 9 0.0263
33 MULTIMORBIDITY 31 0.0259
34 SHOCK HYPOGLYCAEMIC 12 0.0252
35 EPISCLERITIS 17 0.0246
36 INSULINOMA 4 0.0226
37 SUPERINFECTION 32 0.0213
38 RHINALGIA 56 0.0204
39 GENITAL ABSCESS 8 0.0198
40 NON-CARDIOGENIC PULMONARY OEDEMA 20 0.0189
41 SCROTAL ABSCESS 7 0.0185
42 BLINDNESS CORTICAL 9 0.0184
43 ARTERIOSCLEROSIS CORONARY ARTERY 120 0.0181
44 HYPOGLYCAEMIC UNCONSCIOUSNESS 35 0.0177
45 OBSTRUCTIVE AIRWAYS DISORDER 178 0.0160
46 BRASH SYNDROME 22 0.0157
47 VASCULITIS 175 0.0150
48 RETINAL ISCHAEMIA 9 0.0147
49 FULL BLOOD COUNT ABNORMAL 155 0.0146
50 TINEA INFECTION 16 0.0145
51 HYPOGLYCAEMIA UNAWARENESS 5 0.0140
52 PERINEAL ABSCESS 6 0.0133
53 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 14 0.0132
54 TRANSPLANT FAILURE 32 0.0130
55 LUNG CONSOLIDATION 36 0.0129
56 ARTERIOSCLEROSIS 120 0.0127
57 CARDIAC FAILURE HIGH OUTPUT 3 0.0124
58 VULVAL ABSCESS 5 0.0122
59 FLUID REPLACEMENT 4 0.0118
60 PNEUMONITIS ASPIRATION 4 0.0117
61 ASPARTATE AMINOTRANSFERASE DECREASED 6 0.0113
62 NEPHROGENIC ANAEMIA 52 0.0112
63 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 4 0.0104
64 NASAL DISCOMFORT 81 0.0102
65 TINEA PEDIS 16 0.0100
66 COLOUR BLINDNESS 9 0.0098
67 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 31 0.0094
68 PULMONARY FIBROSIS 179 0.0093
69 COMPARTMENT SYNDROME 24 0.0092
70 BLOOD OSMOLARITY INCREASED 3 0.0091
71 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 155 0.0091
72 CYSTOID MACULAR OEDEMA 17 0.0090
73 ANAEMIA OF CHRONIC DISEASE 8 0.0088
74 DISTRIBUTIVE SHOCK 20 0.0088
75 NODULE 113 0.0086
76 ACUTE LUNG INJURY 10 0.0084
77 ALANINE AMINOTRANSFERASE DECREASED 6 0.0083
78 COMA SCALE ABNORMAL 24 0.0083
79 DIABETIC RETINOPATHY 28 0.0082
80 DIABETIC GASTROPARESIS 3 0.0082
81 OESOPHAGEAL OBSTRUCTION 7 0.0081
82 HAEMOPTYSIS 224 0.0080
83 ANION GAP 5 0.0079
84 OPTIC NERVE INJURY 9 0.0078
85 EMBOLISM ARTERIAL 9 0.0075
86 ACUTE LEFT VENTRICULAR FAILURE 5 0.0074
87 HYPERPARATHYROIDISM SECONDARY 18 0.0072
88 PANCREATECTOMY 4 0.0072
89 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 39 0.0072
90 PULMONARY VENO-OCCLUSIVE DISEASE 5 0.0071
91 ADMINISTRATION SITE PAIN 8 0.0069
92 CARDIOGENIC SHOCK 97 0.0068
93 INFLAMMATORY MARKER INCREASED 33 0.0067
94 URINE KETONE BODY PRESENT 10 0.0063
95 PERIRECTAL ABSCESS 7 0.0063
96 PULSELESS ELECTRICAL ACTIVITY 25 0.0060
97 HYPOGLYCAEMIC COMA 17 0.0059
98 NODAL ARRHYTHMIA 5 0.0058
99 ENDOCRINE OPHTHALMOPATHY 5 0.0058
100 HYPOPERFUSION 6 0.0057
101 RALES 33 0.0057
102 HYPOGLYCAEMIA 271 0.0056
103 OPTIC ATROPHY 9 0.0055
104 HYPOTHYROIDISM 171 0.0053
105 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 14 0.0053
106 BACTERIURIA 3 0.0053
107 PULSE ABSENT 25 0.0053
108 BEZOAR 7 0.0051
109 HYPOXIA 178 0.0050
110 SINUS PAIN 11 0.0047
111 PSEUDOMONAL BACTERAEMIA 4 0.0047
112 CARDIOACTIVE DRUG LEVEL INCREASED 6 0.0046
113 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 9 0.0046
114 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 10 0.0045
115 ELECTROCARDIOGRAM T WAVE INVERSION 10 0.0045
116 END STAGE RENAL DISEASE 82 0.0045
117 CARDIOMEGALY 53 0.0043
118 NECROTISING FASCIITIS 15 0.0043
119 HYPERVOLAEMIA 21 0.0042
120 GROIN ABSCESS 5 0.0042
121 BLOOD GLUCOSE DECREASED 198 0.0041
122 CHOLANGITIS ACUTE 3 0.0040
123 ELECTROCARDIOGRAM PR PROLONGATION 3 0.0039
124 EXTRADURAL ABSCESS 3 0.0038
125 POLYOMAVIRUS VIRAEMIA 4 0.0038
126 LUNG DISORDER 184 0.0038
127 ANION GAP INCREASED 5 0.0037
128 CARBON DIOXIDE INCREASED 5 0.0037
129 PNEUMONIA STAPHYLOCOCCAL 7 0.0035
130 CARDIAC DYSFUNCTION 13 0.0035
131 LUMBAR RADICULOPATHY 4 0.0035
132 NODAL RHYTHM 5 0.0034
133 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 164 0.0034
134 PRODUCTIVE COUGH 162 0.0034
135 MACULAR OEDEMA 19 0.0034
136 BLOOD ALBUMIN INCREASED 3 0.0034
137 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 3 0.0034
138 REBOUND ACID HYPERSECRETION 10 0.0033
139 HAEMODYNAMIC INSTABILITY 25 0.0033
140 CERUMEN IMPACTION 3 0.0033
141 MYOCARDIAL ISCHAEMIA 37 0.0032
142 DIABETIC COMA 9 0.0032
143 HYPOTHERMIA 32 0.0032
144 BRADYCARDIA 167 0.0031
145 TONIC CLONIC MOVEMENTS 4 0.0031
146 WHEEZING 181 0.0030
147 SHOCK 69 0.0030
148 ATRIOVENTRICULAR BLOCK FIRST DEGREE 13 0.0030
149 METABOLIC ENCEPHALOPATHY 9 0.0030
150 RENAL TUBULAR NECROSIS 29 0.0030
151 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 26 0.0029
152 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 15 0.0029
153 BLOOD CHLORIDE INCREASED 5 0.0029
154 PUPIL FIXED 5 0.0029
155 HYPERAMMONAEMIC ENCEPHALOPATHY 5 0.0029
156 INTENTIONAL OVERDOSE 181 0.0028
157 IMPAIRED GASTRIC EMPTYING 38 0.0028
158 DIABETES MELLITUS INADEQUATE CONTROL 49 0.0028
159 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
160 HYPOVOLAEMIA 16 0.0027
161 NORMOCYTIC ANAEMIA 4 0.0027
162 BLOOD CHLORIDE DECREASED 7 0.0027
163 BLOOD LOSS ANAEMIA 6 0.0026
164 DIABETIC NEUROPATHY 13 0.0026
165 ISCHAEMIA 12 0.0026
166 PNEUMONIA PSEUDOMONAL 4 0.0026
167 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
168 CARBON DIOXIDE DECREASED 3 0.0026
169 ABSCESS LIMB 11 0.0026
170 ANURIA 22 0.0026
171 FUNGAEMIA 4 0.0025
172 THERMAL BURN 18 0.0025
173 CYSTIC FIBROSIS 14 0.0025
174 BILE DUCT STENOSIS 3 0.0025
175 BRONCHIAL HYPERREACTIVITY 3 0.0025
176 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 177 0.0025
177 PANCREATIC CARCINOMA METASTATIC 7 0.0025
178 RENAL HAEMORRHAGE 5 0.0025
179 AMPUTATION 3 0.0024
180 ACUTE RESPIRATORY FAILURE 46 0.0024
181 BRONCHIAL SECRETION RETENTION 3 0.0024
182 ADENOCARCINOMA PANCREAS 3 0.0023
183 LEFT VENTRICULAR FAILURE 8 0.0023
184 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7 0.0023
185 RESPIRATORY DEPRESSION 28 0.0023
186 METHAEMOGLOBINAEMIA 5 0.0022
187 TYPE 1 DIABETES MELLITUS 13 0.0022
188 THERAPEUTIC RESPONSE DELAYED 6 0.0021
189 ACUTE KIDNEY INJURY 324 0.0021
190 CIRCULATORY COLLAPSE 36 0.0021
191 LACTIC ACIDOSIS 68 0.0021
192 LYMPHOCYTE COUNT DECREASED 37 0.0021
193 ILEUS 26 0.0021
194 SINUS BRADYCARDIA 20 0.0021
195 DIZZINESS POSTURAL 20 0.0021
196 ADRENOCORTICAL INSUFFICIENCY ACUTE 4 0.0020
197 CHRONIC KIDNEY DISEASE 153 0.0020
198 BRONCHIOLITIS 7 0.0020
199 BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0019
200 DIASTOLIC DYSFUNCTION 6 0.0019
201 OLIGURIA 12 0.0019
202 MONOCYTE COUNT INCREASED 7 0.0019
203 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
204 INSULIN RESISTANCE 4 0.0019
205 DIABETIC KETOACIDOSIS 46 0.0019
206 METABOLIC ACIDOSIS 61 0.0019
207 CYSTITIS INTERSTITIAL 3 0.0019
208 PROTEIN TOTAL DECREASED 7 0.0019
209 ANAL ABSCESS 10 0.0019
210 SPUTUM INCREASED 4 0.0018
211 CARDIOVASCULAR INSUFFICIENCY 3 0.0018
212 HYPERGLYCAEMIA 67 0.0018
213 BLOOD GLUCOSE FLUCTUATION 20 0.0018
214 ASTHMA 199 0.0018
215 DRUG LEVEL INCREASED 29 0.0018
216 FAILURE TO THRIVE 9 0.0017
217 ACIDOSIS 13 0.0017
218 GROWTH RETARDATION 5 0.0017
219 PANCREATITIS CHRONIC 4 0.0017
220 URINARY TRACT OBSTRUCTION 4 0.0017
221 EMBOLISM 14 0.0017
222 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
223 RENAL TRANSPLANT 6 0.0017
224 CENTRAL VENOUS CATHETERISATION 5 0.0017
225 NEPHROGENIC SYSTEMIC FIBROSIS 5 0.0017
226 EMERGENCY CARE 5 0.0016
227 ESSENTIAL HYPERTENSION 3 0.0016
228 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
229 INTESTINAL ISCHAEMIA 9 0.0016
230 ISCHAEMIC CARDIOMYOPATHY 5 0.0016
231 MULTIPLE ORGAN DYSFUNCTION SYNDROME 46 0.0016
232 MENTAL STATUS CHANGES 45 0.0016
233 NEPHROPATHY 15 0.0016
234 THROMBOSIS 129 0.0016
235 PULMONARY FUNCTION TEST DECREASED 7 0.0016
236 VENTRICULAR HYPERTROPHY 4 0.0016
237 SYSTEMIC CANDIDA 4 0.0016
238 VASODILATATION 4 0.0016
239 URINARY TRACT INFECTION BACTERIAL 4 0.0016
240 HYPERKALAEMIA 53 0.0015
241 ENCEPHALOPATHY 37 0.0015
242 HYPERLIPIDAEMIA 18 0.0015
243 EYE HAEMORRHAGE 20 0.0015
244 ASCITES 44 0.0015
245 HYPOTENSION 300 0.0015
246 LEUKOCYTOSIS 27 0.0015
247 DEVICE RELATED SEPSIS 3 0.0015
248 BRADYPNOEA 4 0.0015
249 SINUS TACHYCARDIA 21 0.0015
250 ACUTE RESPIRATORY DISTRESS SYNDROME 26 0.0015
251 BLOOD PHOSPHORUS INCREASED 4 0.0015
252 EUGLYCAEMIC DIABETIC KETOACIDOSIS 6 0.0015
253 PULMONARY EMBOLISM 138 0.0015
254 RED BLOOD CELL COUNT INCREASED 4 0.0014
255 EOSINOPHILIC OESOPHAGITIS 4 0.0014
256 CARDIAC ARREST 118 0.0014
257 PANCREATIC DISORDER 7 0.0014
258 SUICIDE ATTEMPT 86 0.0014
259 TOXICITY TO VARIOUS AGENTS 238 0.0014
260 CARDIOTOXICITY 12 0.0013
261 MALNUTRITION 15 0.0013
262 URINE ANALYSIS ABNORMAL 4 0.0013
263 DEPRESSED LEVEL OF CONSCIOUSNESS 52 0.0013
264 RENAL FAILURE 173 0.0013
265 RESPIRATORY FAILURE 95 0.0013
266 PIGMENTATION DISORDER 8 0.0013
267 BLOOD POTASSIUM INCREASED 21 0.0013
268 CHOLANGITIS 8 0.0013
269 RHINOVIRUS INFECTION 5 0.0013
270 ESCHERICHIA BACTERAEMIA 3 0.0013
271 VENTRICULAR TACHYCARDIA 21 0.0013
272 VENTRICULAR HYPOKINESIA 4 0.0012
273 LOOSE TOOTH 4 0.0012
274 COMA 59 0.0012
275 FACIAL PAIN 11 0.0012
276 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 5 0.0012
277 DEAFNESS NEUROSENSORY 4 0.0012
278 HYPERNATRAEMIA 6 0.0012
279 SEPSIS 134 0.0012
280 PLEURAL EFFUSION 73 0.0012
281 HYPERTRIGLYCERIDAEMIA 7 0.0012
282 EXCORIATION 3 0.0012
283 OESOPHAGEAL CARCINOMA 35 0.0012
284 DIABETIC COMPLICATION 3 0.0012
285 REGURGITATION 4 0.0012
286 PULMONARY OEDEMA 52 0.0012
287 CATHETER SITE PAIN 3 0.0012
288 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
289 AORTIC STENOSIS 4 0.0011
290 DIVERTICULUM INTESTINAL 5 0.0011
291 DIALYSIS 16 0.0011
292 BLOOD POTASSIUM ABNORMAL 3 0.0011
293 AREFLEXIA 3 0.0011
294 RHINITIS ALLERGIC 5 0.0011
295 SENSORY DISTURBANCE 18 0.0011
296 TUBULOINTERSTITIAL NEPHRITIS 21 0.0011
297 HICCUPS 9 0.0011
298 UROSEPSIS 10 0.0011
299 CHOLECYSTITIS INFECTIVE 3 0.0011
300 COAGULOPATHY 18 0.0011
301 NEUTROPHIL COUNT INCREASED 11 0.0011
302 HAEMODIALYSIS 9 0.0011
303 ANGIOPATHY 6 0.0011
304 BLOOD GLUCOSE INCREASED 201 0.0011
305 CHRONIC SINUSITIS 4 0.0011
306 CHOLECYSTITIS ACUTE 6 0.0011
307 SPINAL COLUMN STENOSIS 5 0.0011
308 SEPTIC SHOCK 46 0.0011
309 RHABDOMYOLYSIS 44 0.0011
310 PSEUDOMONAS INFECTION 9 0.0010
311 RECALLED PRODUCT ADMINISTERED 10 0.0010
312 SUBCUTANEOUS ABSCESS 5 0.0010
313 ATELECTASIS 10 0.0010
314 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
315 FLUID OVERLOAD 15 0.0010
316 URINE OUTPUT DECREASED 9 0.0010
317 PRODUCT LABEL CONFUSION 6 0.0010
318 BLOOD GLUCOSE ABNORMAL 19 0.0010
319 EPIGASTRIC DISCOMFORT 4 0.0010
320 ORAL INFECTION 4 0.0010
321 DECREASED INTEREST 6 0.0010
322 ALTERED STATE OF CONSCIOUSNESS 22 0.0010
323 EXPIRED DRUG ADMINISTERED 5 0.0010
324 RENAL INJURY 30 0.0010
325 BLOOD ALBUMIN DECREASED 8 0.0010
326 GANGRENE 6 0.0010
327 ECONOMIC PROBLEM 15 0.0010
328 TOE AMPUTATION 5 0.0010
329 DYSLIPIDAEMIA 5 0.0010
330 DECUBITUS ULCER 8 0.0010
331 POLYURIA 8 0.0010
332 BRAIN DEATH 3 0.0010
333 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
334 BLOOD CREATININE DECREASED 3 0.0010
335 BLOOD UREA INCREASED 16 0.0010
336 BLOOD LACTIC ACID INCREASED 5 0.0009
337 GAMMA-GLUTAMYLTRANSFERASE INCREASED 21 0.0009
338 HYPOPHOSPHATAEMIA 7 0.0009
339 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
340 ELECTROLYTE IMBALANCE 11 0.0009
341 CARDIAC FAILURE CHRONIC 4 0.0009
342 KETOACIDOSIS 7 0.0009
343 HYPOMAGNESAEMIA 13 0.0009
344 UNRESPONSIVE TO STIMULI 24 0.0009
345 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
346 ATRIOVENTRICULAR BLOCK 7 0.0009
347 EXPIRED PRODUCT ADMINISTERED 30 0.0009
348 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
349 SLEEP DISORDER 63 0.0009
350 HYPOKALAEMIA 41 0.0009
351 CARDIAC FAILURE CONGESTIVE 71 0.0009
352 VASCULAR DEVICE INFECTION 4 0.0009
353 OBESITY 14 0.0009
354 ATRIAL FLUTTER 7 0.0009
355 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
356 LARGE INTESTINE POLYP 6 0.0009
357 UMBILICAL HERNIA 4 0.0009
358 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
359 CONDITION AGGRAVATED 258 0.0008
360 COVID-19 PNEUMONIA 10 0.0008
361 BACTERAEMIA 10 0.0008
362 PNEUMONIA ASPIRATION 21 0.0008
363 LOWER RESPIRATORY TRACT INFECTION 38 0.0008
364 PULMONARY CONGESTION 11 0.0008
365 ENTEROCOCCAL INFECTION 4 0.0008
366 STAPHYLOCOCCAL SEPSIS 4 0.0008
367 OVARIAN CYST 8 0.0008
368 EYE PAIN 45 0.0008
369 ANXIETY 226 0.0008
370 LUNG INFILTRATION 7 0.0008
371 TROPONIN INCREASED 6 0.0008
372 PATHOLOGICAL FRACTURE 4 0.0008
373 RENAL FAILURE CHRONIC 6 0.0008
374 POOR QUALITY DRUG ADMINISTERED 5 0.0008
375 INCOHERENT 5 0.0008
376 INTERNATIONAL NORMALISED RATIO INCREASED 22 0.0008
377 PULMONARY HYPERTENSION 16 0.0008
378 PULMONARY HAEMORRHAGE 6 0.0008
379 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
380 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
381 PNEUMONIA BACTERIAL 7 0.0008
382 RENAL IMPAIRMENT 64 0.0008
383 PULMONARY ARTERIAL HYPERTENSION 11 0.0008
384 IRON DEFICIENCY ANAEMIA 7 0.0008
385 RENAL CYST 6 0.0008
386 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
387 CELLULITIS 38 0.0008
388 AZOTAEMIA 3 0.0008
389 HEPATIC ENCEPHALOPATHY 7 0.0007
390 SENSORY LOSS 6 0.0007
391 ENURESIS 3 0.0007
392 BLOOD SODIUM DECREASED 14 0.0007
393 BRONCHIECTASIS 5 0.0007
394 GINGIVITIS 4 0.0007
395 RESPIRATORY DISTRESS 20 0.0007
396 PAIN IN EXTREMITY 212 0.0007
397 LOSS OF CONSCIOUSNESS 92 0.0007
398 OSTEOMYELITIS 13 0.0007
399 THROMBOCYTOPENIA 80 0.0007
400 RIGHT VENTRICULAR FAILURE 5 0.0007
401 HYPONATRAEMIA 40 0.0007
402 PERIORBITAL SWELLING 4 0.0007
403 BUNDLE BRANCH BLOCK LEFT 3 0.0007
404 SUBDURAL HAEMATOMA 10 0.0007
405 BRAIN INJURY 7 0.0007
406 MULTI-ORGAN FAILURE 12 0.0007
407 PYELONEPHRITIS 6 0.0007
408 MAJOR DEPRESSION 5 0.0007
409 SPINAL OSTEOARTHRITIS 6 0.0007
410 CARDIOMYOPATHY 10 0.0007
411 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
412 CARDIAC PACEMAKER INSERTION 4 0.0007
413 HYDRONEPHROSIS 5 0.0007
414 DYSPNOEA 375 0.0007
415 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
416 OSTEOPENIA 10 0.0007
417 ACUTE HEPATIC FAILURE 9 0.0007
418 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 36 0.0007
419 SMALL INTESTINAL OBSTRUCTION 8 0.0006
420 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
421 HAEMOLYSIS 5 0.0006
422 SCOLIOSIS 4 0.0006
423 OVERDOSE 139 0.0006
424 HEPATIC STEATOSIS 12 0.0006
425 DEPRESSED MOOD 34 0.0006
426 HYPOALBUMINAEMIA 5 0.0006
427 MULTIPLE INJURIES 4 0.0006
428 SPINAL DISORDER 6 0.0006
429 DRUG SCREEN POSITIVE 5 0.0006
430 VENTRICULAR FIBRILLATION 7 0.0006
431 LACRIMATION INCREASED 19 0.0006
432 SLEEP APNOEA SYNDROME 12 0.0006
433 ABSCESS 10 0.0006
434 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
435 PANCREATITIS ACUTE 14 0.0006
436 HAEMOGLOBIN ABNORMAL 4 0.0006
437 GASTROENTERITIS 9 0.0006
438 SEIZURE 71 0.0006
439 COELIAC DISEASE 6 0.0006
440 BREATH SOUNDS ABNORMAL 3 0.0006
441 ESCHERICHIA INFECTION 5 0.0006
442 TACHYCARDIA 54 0.0006
443 HOSPICE CARE 6 0.0006
444 HAEMATOCRIT DECREASED 12 0.0006
445 ACUTE CORONARY SYNDROME 5 0.0006
446 ALANINE AMINOTRANSFERASE INCREASED 37 0.0006
447 CARDIAC FAILURE ACUTE 4 0.0006
448 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
449 POST-TRAUMATIC STRESS DISORDER 4 0.0006
450 CORONARY ARTERY STENOSIS 3 0.0006
451 PERITONITIS BACTERIAL 6 0.0006
452 DRUG TOLERANCE 3 0.0006
453 COLITIS ISCHAEMIC 4 0.0006
454 EYE MOVEMENT DISORDER 4 0.0006
455 TENDERNESS 6 0.0006
456 DRUG INTERACTION 91 0.0006
457 CYTOPENIA 7 0.0006
458 SYNCOPE 57 0.0006
459 PNEUMONIA 184 0.0006
460 INCONTINENCE 6 0.0006
461 NEPHROLITHIASIS 26 0.0006
462 BLOOD POTASSIUM DECREASED 17 0.0006
463 BLINDNESS 23 0.0006
464 HAEMORRHOIDS 11 0.0006
465 WRONG DRUG ADMINISTERED 5 0.0006
466 OEDEMA 30 0.0006
467 LIMB INJURY 15 0.0006
468 SKIN LACERATION 6 0.0006
469 CARDIO-RESPIRATORY ARREST 23 0.0005
470 CYTOKINE RELEASE SYNDROME 11 0.0005
471 ASTHENOPIA 3 0.0005
472 STAPHYLOCOCCAL INFECTION 18 0.0005
473 SKIN ULCER 14 0.0005
474 SWELLING 50 0.0005
475 FISTULA 6 0.0005
476 ANHEDONIA 14 0.0005
477 CEREBRAL INFARCTION 13 0.0005
478 HEPATIC FAILURE 16 0.0005
479 ELECTROCARDIOGRAM QT PROLONGED 19 0.0005
480 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
481 DYSPHAGIA 50 0.0005
482 DIABETES MELLITUS 40 0.0005
483 LIPASE INCREASED 4 0.0005
484 SKIN EXFOLIATION 44 0.0005
485 BLOOD BILIRUBIN INCREASED 14 0.0005
486 TACHYPNOEA 7 0.0005
487 APNOEA 4 0.0005
488 ATRIAL FIBRILLATION 50 0.0005
489 VITAMIN D DEFICIENCY 5 0.0005
490 FEBRILE NEUTROPENIA 34 0.0005
491 PANCREATITIS 27 0.0005
492 CYSTITIS 16 0.0005
493 DEHYDRATION 67 0.0005
494 NO ADVERSE EVENT 91 0.0005
495 BURNING SENSATION 35 0.0005
496 GASTROENTERITIS VIRAL 9 0.0005
497 CORONARY ARTERY DISEASE 15 0.0005
498 RENAL FAILURE ACUTE 21 0.0005
499 MUSCLE DISORDER 4 0.0005
500 POST PROCEDURAL INFECTION 4 0.0005
501 SHOCK HAEMORRHAGIC 4 0.0005
502 BLOOD CREATININE INCREASED 32 0.0005
503 ANAPHYLACTIC REACTION 27 0.0005
504 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
505 CHOLELITHIASIS 16 0.0005
506 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
507 SPINAL COMPRESSION FRACTURE 4 0.0005
508 POOR VENOUS ACCESS 5 0.0005
509 HEPATIC CIRRHOSIS 9 0.0005
510 HYPOCALCAEMIA 9 0.0005
511 VOMITING 222 0.0005
512 PULMONARY MASS 7 0.0005
513 ENTERITIS 3 0.0005
514 ROTATOR CUFF SYNDROME 6 0.0005
515 HIP FRACTURE 15 0.0005
516 BLOOD MAGNESIUM DECREASED 4 0.0005
517 HIATUS HERNIA 6 0.0005
518 MUSCLE STRAIN 4 0.0005
519 HYSTERECTOMY 4 0.0005
520 PRODUCT PRESCRIBING ISSUE 10 0.0005
521 INSURANCE ISSUE 7 0.0005
522 DEVICE RELATED INFECTION 7 0.0005
523 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
524 URINARY TRACT INFECTION 77 0.0005
525 RESPIRATORY RATE INCREASED 4 0.0005
526 EJECTION FRACTION DECREASED 7 0.0004
527 HYPERTENSIVE CRISIS 5 0.0004
528 DEEP VEIN THROMBOSIS 29 0.0004
529 MYOSITIS 4 0.0004
530 SWELLING FACE 29 0.0004
531 PRODUCT ADMINISTRATION ERROR 9 0.0004
532 BLOOD CALCIUM DECREASED 5 0.0004
533 SINUS CONGESTION 6 0.0004
534 STATUS EPILEPTICUS 5 0.0004
535 HEAD INJURY 14 0.0004
536 ACUTE MYOCARDIAL INFARCTION 13 0.0004
537 PNEUMONITIS 12 0.0004
538 RESPIRATORY TRACT CONGESTION 7 0.0004
539 ACCIDENTAL OVERDOSE 16 0.0004
540 GRAND MAL CONVULSION 4 0.0004
541 PERICARDIAL EFFUSION 10 0.0004
542 GASTROINTESTINAL HAEMORRHAGE 36 0.0004
543 HYPOPHAGIA 11 0.0004
544 DIARRHOEA HAEMORRHAGIC 4 0.0004
545 ANAPHYLACTIC SHOCK 11 0.0004
546 DUODENAL ULCER 3 0.0004
547 SQUAMOUS CELL CARCINOMA 4 0.0004
548 DYSPNOEA EXERTIONAL 16 0.0004
549 CHOLECYSTITIS 5 0.0004
550 HAEMOGLOBIN DECREASED 43 0.0004
551 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
552 LETHARGY 24 0.0004
553 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
554 HYPERTHYROIDISM 6 0.0004
555 OSTEOPOROSIS 17 0.0004
556 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
557 ADRENAL INSUFFICIENCY 5 0.0004
558 NEURALGIA 10 0.0004
559 COUGH 115 0.0004
560 SPINAL OPERATION 5 0.0004
561 ARRHYTHMIA 19 0.0004
562 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
563 BRAIN OEDEMA 5 0.0004
564 TOOTH ABSCESS 4 0.0004
565 SUBARACHNOID HAEMORRHAGE 4 0.0004
566 BOWEL MOVEMENT IRREGULARITY 3 0.0004
567 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
568 HOSPITALISATION 60 0.0004
569 UPPER RESPIRATORY TRACT INFECTION 18 0.0004
570 PAIN IN JAW 11 0.0004
571 MUSCULOSKELETAL CHEST PAIN 6 0.0004
572 TEMPERATURE INTOLERANCE 4 0.0004
573 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
574 APHTHOUS ULCER 3 0.0004
575 LUNG INFECTION 6 0.0004
576 TYPE 2 DIABETES MELLITUS 13 0.0004
577 PHARMACEUTICAL PRODUCT COMPLAINT 10 0.0004
578 RESTLESS LEGS SYNDROME 7 0.0004
579 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
580 TRANSFUSION 4 0.0004
581 THERAPY NON-RESPONDER 17 0.0004
582 SCIATICA 6 0.0004
583 EYE SWELLING 14 0.0004
584 BLOOD PRESSURE DECREASED 25 0.0004
585 BLOOD DISORDER 3 0.0004
586 BREAST CANCER METASTATIC 4 0.0004
587 FOOT FRACTURE 7 0.0004
588 OEDEMA PERIPHERAL 45 0.0004
589 OESOPHAGITIS 4 0.0004
590 SEROTONIN SYNDROME 7 0.0004
591 RESPIRATORY ARREST 10 0.0004
592 NERVE INJURY 4 0.0004
593 DEMENTIA 10 0.0004
594 MASS 5 0.0004
595 SNEEZING 8 0.0004
596 PLATELET COUNT DECREASED 38 0.0004
597 CANDIDA INFECTION 6 0.0004
598 SEASONAL ALLERGY 5 0.0004
599 DERMATITIS CONTACT 4 0.0004
600 MICTURITION URGENCY 4 0.0003
601 INTERNAL HAEMORRHAGE 4 0.0003
602 RED BLOOD CELL COUNT DECREASED 10 0.0003
603 CONVULSION 20 0.0003
604 CARDIAC FAILURE 28 0.0003
605 ACCIDENTAL UNDERDOSE 5 0.0003
606 CARDIAC MURMUR 3 0.0003
607 TASTE DISORDER 7 0.0003
608 MENTAL DISORDER 15 0.0003
609 ORTHOSTATIC HYPOTENSION 6 0.0003
610 COLITIS 13 0.0003
611 GASTRITIS 9 0.0003
612 HEART RATE DECREASED 12 0.0003
613 SPLENOMEGALY 4 0.0003
614 ASPARTATE AMINOTRANSFERASE INCREASED 18 0.0003
615 PERITONITIS 7 0.0003
616 NEUROPATHY PERIPHERAL 32 0.0003
617 HAEMORRHAGE INTRACRANIAL 5 0.0003
618 HALLUCINATION, VISUAL 7 0.0003
619 TOOTHACHE 6 0.0003
620 VISUAL IMPAIRMENT 41 0.0003
621 CHEST PAIN 61 0.0003
622 BONE DISORDER 6 0.0003
623 PRESYNCOPE 8 0.0003
624 DYSURIA 12 0.0003
625 ANAEMIA 62 0.0003
626 FALL 108 0.0003
627 HYPERCALCAEMIA 4 0.0003
628 PYREXIA 112 0.0003
629 GENERALISED OEDEMA 4 0.0003
630 EXTRAPYRAMIDAL DISORDER 8 0.0003
631 PANCYTOPENIA 18 0.0003
632 WOUND 9 0.0003
633 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
634 OXYGEN SATURATION DECREASED 18 0.0003
635 HYPERHIDROSIS 41 0.0003
636 ABDOMINAL PAIN 74 0.0003
637 DERMATITIS ALLERGIC 4 0.0003
638 MUSCLE ATROPHY 4 0.0003
639 PROTEINURIA 6 0.0003
640 PNEUMOTHORAX 5 0.0003
641 ULCER 5 0.0003
642 THROAT IRRITATION 14 0.0003
643 POLLAKIURIA 13 0.0003
644 PANCREATIC CARCINOMA 9 0.0003
645 INFECTION 45 0.0003
646 TREATMENT NONCOMPLIANCE 17 0.0003
647 RHINORRHOEA 20 0.0003
648 HAEMATOMA 8 0.0003
649 EAR PAIN 6 0.0003
650 AUTOIMMUNE DISORDER 3 0.0003
651 CHOKING 6 0.0003
652 CEREBRAL HAEMORRHAGE 11 0.0003
653 OSTEOARTHRITIS 13 0.0003
654 DEAFNESS 8 0.0003
655 PERIPHERAL SWELLING 47 0.0003
656 LABORATORY TEST ABNORMAL 9 0.0003
657 MULTIPLE FRACTURES 5 0.0003
658 NECK PAIN 17 0.0003
659 CONFUSIONAL STATE 49 0.0003
660 SINUS DISORDER 6 0.0003
661 BLOOD PRESSURE ABNORMAL 6 0.0003
662 CYTOMEGALOVIRUS INFECTION 5 0.0003
663 FUNGAL INFECTION 10 0.0003
664 HEADACHE 188 0.0003
665 NAUSEA 237 0.0003
666 GAIT INABILITY 10 0.0003
667 EMPHYSEMA 3 0.0003
668 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
669 DRUG INEFFECTIVE 389 0.0003
670 BODY TEMPERATURE INCREASED 6 0.0003
671 PALLOR 8 0.0003
672 DRUG TOXICITY 4 0.0003
673 LIVER DISORDER 13 0.0003
674 EAR DISCOMFORT 3 0.0003
675 SCAR 5 0.0003
676 INTESTINAL OBSTRUCTION 11 0.0003
677 RIB FRACTURE 6 0.0003
678 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
679 MUSCULAR WEAKNESS 33 0.0003
680 LOCALISED INFECTION 7 0.0003
681 CONSTIPATION 63 0.0003
682 ORAL DISCOMFORT 4 0.0003
683 UNDERDOSE 21 0.0003
684 NEUROTOXICITY 5 0.0003
685 BLOOD TEST ABNORMAL 4 0.0003
686 ASTHENIA 107 0.0003
687 INJURY 20 0.0003
688 BLINDNESS UNILATERAL 4 0.0003
689 MALAISE 124 0.0003
690 DIZZINESS 141 0.0003
691 HEAD DISCOMFORT 5 0.0003
692 THIRST 5 0.0003
693 PARALYSIS 4 0.0003
694 ANGINA PECTORIS 8 0.0003
695 SOMNOLENCE 56 0.0003
696 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
697 VISION BLURRED 38 0.0003
698 MYELODYSPLASTIC SYNDROME 4 0.0003
699 ANOSMIA 4 0.0003
700 HAEMATEMESIS 7 0.0003
701 BIPOLAR DISORDER 3 0.0003
702 LIVER FUNCTION TEST ABNORMAL 8 0.0003
703 IMPAIRED HEALING 9 0.0003
704 HYPOAESTHESIA 41 0.0003
705 ASPIRATION 3 0.0003
706 MELAENA 6 0.0003
707 APPLICATION SITE PAIN 6 0.0003
708 INCORRECT DOSE ADMINISTERED 62 0.0003
709 EXTRA DOSE ADMINISTERED 11 0.0003
710 DENTAL CARIES 3 0.0003
711 DYSKINESIA 11 0.0003
712 URINARY INCONTINENCE 8 0.0003
713 URINARY RETENTION 9 0.0003
714 DIPLOPIA 7 0.0003
715 THINKING ABNORMAL 5 0.0003
716 EYE PRURITUS 9 0.0003
717 SPEECH DISORDER 14 0.0003
718 DYSARTHRIA 10 0.0003
719 PRODUCT DOSE OMISSION ISSUE 78 0.0003
720 SKIN BURNING SENSATION 19 0.0003
721 COMPLETED SUICIDE 22 0.0003
722 HEART RATE INCREASED 26 0.0003
723 BLOOD PRESSURE INCREASED 40 0.0003
724 PRODUCT DOSE OMISSION 17 0.0003
725 POST PROCEDURAL COMPLICATION 5 0.0003
726 LOWER LIMB FRACTURE 5 0.0003
727 GLAUCOMA 5 0.0003
728 THYROID DISORDER 4 0.0003
729 EMOTIONAL DISORDER 8 0.0003
730 DELIRIUM 9 0.0003
731 LYMPHOMA 4 0.0003
732 NEOPLASM PROGRESSION 9 0.0003
733 ANKLE FRACTURE 4 0.0003
734 ACUTE MYELOID LEUKAEMIA 4 0.0003
735 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
736 PLASMA CELL MYELOMA 10 0.0003
737 RECTAL HAEMORRHAGE 11 0.0003
738 DRUG DOSE OMISSION BY DEVICE 20 0.0003
739 NASAL CONGESTION 15 0.0003
740 KIDNEY INFECTION 5 0.0003
741 DECREASED APPETITE 59 0.0003
742 EPISTAXIS 19 0.0003
743 ABDOMINAL PAIN UPPER 52 0.0003
744 PROCEDURAL PAIN 7 0.0003
745 MIGRAINE 24 0.0003
746 GENERAL PHYSICAL HEALTH DETERIORATION 29 0.0003
747 ABDOMINAL DISTENSION 26 0.0002
748 DEATH 213 0.0002
749 INTENTIONAL DOSE OMISSION 7 0.0002
750 INJURY ASSOCIATED WITH DEVICE 5 0.0002
751 NEUTROPHIL COUNT DECREASED 10 0.0002
752 CEREBROVASCULAR ACCIDENT 41 0.0002
753 NEEDLE ISSUE 7 0.0002
754 DRY EYE 12 0.0002
755 VIRAL INFECTION 8 0.0002
756 GAIT DISTURBANCE 46 0.0002
757 DIARRHOEA 153 0.0002
758 WEIGHT DECREASED 66 0.0002
759 CARDIOVASCULAR DISORDER 6 0.0002
760 HEMIPARESIS 4 0.0002
761 RENAL DISORDER 11 0.0002
762 HYPERTENSION 50 0.0002
763 OFF LABEL USE 206 0.0002
764 PARAESTHESIA 37 0.0002
765 MYOCARDIAL INFARCTION 41 0.0002
766 JOINT INJURY 5 0.0002
767 RESPIRATORY DISORDER 7 0.0002
768 DYSPEPSIA 23 0.0002
769 IRRITABLE BOWEL SYNDROME 5 0.0002
770 DEPRESSION 53 0.0002
771 LIVER FUNCTION TEST INCREASED 5 0.0002
772 BACK PAIN 54 0.0002
773 POOR QUALITY SLEEP 5 0.0002
774 FAECES DISCOLOURED 5 0.0002
775 RESPIRATORY TRACT INFECTION 6 0.0002
776 SYRINGE ISSUE 4 0.0002
777 DRUG ADMINISTRATION ERROR 7 0.0002
778 METASTASES TO LIVER 4 0.0002
779 DISORIENTATION 9 0.0002
780 COLD SWEAT 4 0.0002
781 EAR INFECTION 6 0.0002
782 NERVOUS SYSTEM DISORDER 7 0.0002
783 GALLBLADDER DISORDER 4 0.0002
784 GOUT 4 0.0002
785 CHROMATURIA 5 0.0002
786 CORONARY ARTERY OCCLUSION 3 0.0002
787 CATARACT 13 0.0002
788 NIGHT SWEATS 7 0.0002
789 MEDICATION ERROR 12 0.0002
790 COORDINATION ABNORMAL 3 0.0002
791 BACTERIAL INFECTION 4 0.0002
792 CARPAL TUNNEL SYNDROME 3 0.0002
793 DEVICE OCCLUSION 3 0.0002
794 EYE DISORDER 7 0.0002
795 TARDIVE DYSKINESIA 6 0.0002
796 UNEVALUABLE EVENT 16 0.0002
797 OCULAR HYPERAEMIA 10 0.0002
798 BRONCHOSPASM 3 0.0002
799 PRODUCT PRESCRIBING ERROR 5 0.0002
800 FEELING JITTERY 4 0.0002
801 HYPERSOMNIA 6 0.0002
802 HYPOACUSIS 9 0.0002
803 EYE IRRITATION 12 0.0002
804 CONTUSION 20 0.0002
805 ERUCTATION 4 0.0002
806 MENTAL IMPAIRMENT 5 0.0002
807 INFLUENZA 23 0.0002
808 COVID-19 36 0.0002
809 HAEMATURIA 7 0.0002
810 AGITATION 15 0.0002
811 INJECTION SITE URTICARIA 5 0.0002
812 PSYCHOTIC DISORDER 6 0.0002
813 OSTEONECROSIS OF JAW 5 0.0002
814 PRODUCT USE IN UNAPPROVED INDICATION 50 0.0002
815 COLON CANCER 3 0.0002
816 GASTROINTESTINAL DISORDER 18 0.0002
817 AGEUSIA 5 0.0002
818 AGGRESSION 10 0.0002
819 APHASIA 6 0.0002
820 EMOTIONAL DISTRESS 24 0.0002
821 BLOOD COUNT ABNORMAL 3 0.0002
822 FATIGUE 154 0.0002
823 ABDOMINAL PAIN LOWER 5 0.0002
824 DEVICE FAILURE 3 0.0002
825 VERTIGO 12 0.0002
826 BALANCE DISORDER 17 0.0002
827 FLUID RETENTION 10 0.0002
828 DRUG DISPENSING ERROR 3 0.0002
829 CHILLS 23 0.0002
830 MUSCLE SPASMS 36 0.0002
831 FEELING HOT 12 0.0002
832 HEPATITIS 5 0.0002
833 CHEST DISCOMFORT 20 0.0002
834 RASH 85 0.0002
835 INFLUENZA LIKE ILLNESS 16 0.0002
836 INTENTIONAL PRODUCT MISUSE 17 0.0002
837 TOOTH LOSS 4 0.0002
838 COGNITIVE DISORDER 9 0.0002
839 CARDIAC DISORDER 18 0.0002
840 PANIC ATTACK 7 0.0002
841 DERMATITIS 4 0.0002
842 MUSCULOSKELETAL PAIN 10 0.0002
843 PAIN 116 0.0002
844 DYSPHONIA 11 0.0002
845 EATING DISORDER 4 0.0002
846 FEAR 5 0.0002
847 JAUNDICE 5 0.0002
848 SKIN CANCER 4 0.0002
849 THROAT TIGHTNESS 5 0.0002
850 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
851 THERAPEUTIC RESPONSE DECREASED 11 0.0002
852 HAEMATOCHEZIA 10 0.0002
853 VISUAL ACUITY REDUCED 6 0.0002
854 DIVERTICULITIS 5 0.0002
855 TOOTH DISORDER 4 0.0002
856 NEOPLASM MALIGNANT 12 0.0002
857 HEPATOTOXICITY 4 0.0002
858 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
859 HEART RATE IRREGULAR 4 0.0002
860 HEPATIC ENZYME INCREASED 12 0.0002
861 MEMORY IMPAIRMENT 24 0.0002
862 TINNITUS 8 0.0002
863 MUSCLE TWITCHING 4 0.0002
864 OROPHARYNGEAL PAIN 16 0.0002
865 BLOOD CHOLESTEROL INCREASED 8 0.0002
866 PALPITATIONS 20 0.0002
867 SURGERY 10 0.0002
868 LUNG NEOPLASM MALIGNANT 7 0.0002
869 NEUTROPENIA 23 0.0002
870 PSORIASIS 22 0.0002
871 WHITE BLOOD CELL COUNT DECREASED 18 0.0002
872 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
873 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
874 ILLNESS 17 0.0002
875 FIBROMYALGIA 4 0.0002
876 BRONCHITIS 12 0.0002
877 ABASIA 4 0.0002
878 DRY MOUTH 13 0.0002
879 LEUKOPENIA 8 0.0002
880 BONE DENSITY DECREASED 5 0.0002
881 HOT FLUSH 12 0.0002
882 BLOOD URINE PRESENT 3 0.0002
883 GASTRIC CANCER 4 0.0002
884 TREATMENT FAILURE 13 0.0002
885 HERPES ZOSTER 9 0.0002
886 DRUG PRESCRIBING ERROR 3 0.0002
887 SINUSITIS 16 0.0002
888 URTICARIA 26 0.0002
889 ABDOMINAL DISCOMFORT 26 0.0002
890 FEELING ABNORMAL 37 0.0002
891 THERAPY INTERRUPTED 11 0.0002
892 NERVOUSNESS 8 0.0002
893 DISEASE PROGRESSION 18 0.0002
894 DISABILITY 3 0.0002
895 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
896 ERYTHEMA 31 0.0002
897 COMPLICATION OF DEVICE INSERTION 3 0.0002
898 TREMOR 25 0.0002
899 LIP SWELLING 5 0.0001
900 DISTURBANCE IN ATTENTION 8 0.0001
901 ILL-DEFINED DISORDER 9 0.0001
902 FREQUENT BOWEL MOVEMENTS 4 0.0001
903 RASH PRURITIC 8 0.0001
904 FLUSHING 15 0.0001
905 MOOD ALTERED 4 0.0001
906 INSOMNIA 39 0.0001
907 RASH ERYTHEMATOUS 7 0.0001
908 DEVICE DELIVERY SYSTEM ISSUE 4 0.0001
909 SKIN LESION 4 0.0001
910 ADVERSE DRUG REACTION 13 0.0001
911 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
912 ARTHROPATHY 8 0.0001
913 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
914 LYMPHADENOPATHY 5 0.0001
915 MYELOSUPPRESSION 5 0.0001
916 AMNESIA 9 0.0001
917 VAGINAL HAEMORRHAGE 6 0.0001
918 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001
919 DYSSTASIA 4 0.0001
920 BONE PAIN 8 0.0001
921 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
922 PREMATURE BABY 4 0.0001
923 SUICIDAL IDEATION 12 0.0001
924 EPILEPSY 4 0.0001
925 INJECTION SITE REACTION 9 0.0001
926 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
927 MOBILITY DECREASED 9 0.0001
928 BLISTER 7 0.0001
929 MYALGIA 21 0.0001
930 FLATULENCE 7 0.0001
931 WEIGHT INCREASED 27 0.0001
932 ROAD TRAFFIC ACCIDENT 5 0.0001
933 INJECTION SITE PRURITUS 8 0.0001
934 ADVERSE EVENT 11 0.0001
935 HYPERSENSITIVITY 22 0.0001
936 ANGER 4 0.0001
937 ERECTILE DYSFUNCTION 3 0.0001
938 INFLAMMATION 6 0.0001
939 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
940 EXPOSURE DURING PREGNANCY 7 0.0001
941 PRODUCT USE ISSUE 21 0.0001
942 DEVICE ISSUE 10 0.0001
943 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
944 C-REACTIVE PROTEIN INCREASED 4 0.0001
945 HALLUCINATION 8 0.0001
946 HAEMORRHAGE 11 0.0001
947 ARTHRALGIA 43 0.0001
948 NASOPHARYNGITIS 19 0.0001
949 PRODUCT QUALITY ISSUE 14 0.0001
950 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
951 ABNORMAL BEHAVIOUR 4 0.0001
952 INJECTION SITE BRUISING 8 0.0001
953 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
954 STOMATITIS 6 0.0001
955 PSORIATIC ARTHROPATHY 4 0.0001
956 INJECTION SITE PAIN 30 0.0001
957 THERAPY CESSATION 5 0.0001
958 DRUG-INDUCED LIVER INJURY 3 0.0001
959 DYSGEUSIA 7 0.0001
960 DEVICE DISLOCATION 4 0.0001
961 DRUG DOSE OMISSION 15 0.0001
962 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
963 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
964 SKIN DISCOLOURATION 4 0.0001
965 PROSTATE CANCER 7 0.0001
966 PRURITUS 32 0.0001
967 IRRITABILITY 5 0.0001
968 DRUG INTOLERANCE 8 0.0001
969 INTERSTITIAL LUNG DISEASE 4 0.0001
970 CRYING 3 0.0001
971 DISCOMFORT 5 0.0001
972 INFUSION RELATED REACTION 5 0.0001
973 JOINT SWELLING 9 0.0001
974 DEVICE MALFUNCTION 5 0.0001
975 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
976 DRUG WITHDRAWAL SYNDROME 6 0.0001
977 ACNE 5 0.0001
978 ARTHRITIS 5 0.0001
979 INJECTION SITE HAEMORRHAGE 5 0.0001
980 ALOPECIA 12 0.0001
981 DEVICE DIFFICULT TO USE 4 0.0001
982 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
983 ECZEMA 3 0.0001
984 PRODUCT STORAGE ERROR 5 0.0001
985 DERMATITIS ATOPIC 3 0.0001
986 BLADDER CANCER 3 0.0001
987 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
988 DRUG ABUSE 4 0.0000
989 DRUG DEPENDENCE 7 0.0000
990 INJECTION SITE ERYTHEMA 4 0.0000
991 DRY SKIN 4 0.0000